Efficacy and safety of perampanel monotherapy in patients with focal‐onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open‐label Study 342 (FREEDOM Study)

OBJECTIVE: Our study assessed perampanel monotherapy in patients (aged ≥12 years) with focal‐onset seizures (FOS) with or without focal to bilateral tonic‐clonic seizures (FBTCS) in Japan and South Korea. METHODS: Study 342 (NCT03201900; FREEDOM) is a single‐arm, open‐label, Phase III study. Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Takamichi, Lim, Sung Chul, Ninomiya, Hirotomo, Kubota, Yuichi, Shin, Won Chul, Kim, Dong Wook, Shin, Dong Jin, Hoshida, Tohru, Iida, Koji, Ochiai, Taku, Matsunaga, Risa, Higashiyama, Hiroyuki, Hiramatsu, Hidetaka, Kim, Ji Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278556/
https://www.ncbi.nlm.nih.gov/pubmed/32524053
http://dx.doi.org/10.1002/epi4.12398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278556/
https://www.ncbi.nlm.nih.gov/pubmed/32524053
http://dx.doi.org/10.1002/epi4.12398

Ejemplares similares